Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29988966 | 1.00 | CNR2 (0.98) | CNR2CNR1 | |
| SCHEMBL29362566 | 1.00 | CNR2 (0.98) | CNR2CNR1 | |
| SCHEMBL16201691 | 1.00 | CNR2 (0.98) | CNR2CNR1 | |
| SCHEMBL29361900 | 0.99 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL1707018 | 0.99 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL29375790 | 0.95 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL11983320 | 0.95 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL6325191 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL29988839 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL11983311 | 0.89 | CNR2 (0.78) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220026380-A1 | NUCLEAR MAGNETIC RESONANCE IMPLEMENTED SYNTHETIC INDOLE AND INDAZOLE CANNABINOID DETECTION, IDENTIFICATION, AND QUANTIFICATION | HOFSTRA UNIVERSITY (US) | 2022-01-27 | — | — | US | disclosed |
| EP-2989452-B1 | NUCLEAR MAGNETIC RESONANCE BASED SYNTHETIC INDOLE AND INDAZOLE CANNABINOID DETECTION, IDENTIFICATION, AND QUANTIFICATION | HOFSTRA UNIV (US) | 2021-09-29 | — | — | EP | disclosed |
| US-11085891-B2 | Nuclear magnetic resonance implemented synthetic indole and indazole cannabinoid detection, identification, and quantification | HOFSTRA UNIVERSITY (US) | 2021-08-10 | — | — | US | disclosed |
| WO-2020232350-A1 | ASSAYS FOR SYNTHETIC CANNABINOIDS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2020-11-19 | — | — | WO | disclosed |
| WO-2020232350-A1 | ASSAYS FOR SYNTHETIC CANNABINOIDS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2020-11-19 | — | — | WO | disclosed |
| US-20170210728-A1 | Cannabinergic Nitrate Esters And Related Analogs | NORTHEASTERN UNIVERSITY | 2017-07-27 | — | — | US | disclosed |
| US-9580400-B2 | Cannabinergic nitrate esters and related analogs | NORTHEASTERN UNIVERSITY (US) | 2017-02-28 | — | — | US | disclosed |
| US-20160084779-A1 | NUCLEAR MAGNETIC RESONANCE IMPLEMENTED SYNTHETIC INDOLE AND INDAZOLE CANNABINOID DETECTION, IDENTIFICATION, AND QUANTIFICATION | HOFSTRA UNIVERSITY (US) | 2016-03-24 | — | — | US | disclosed |
| US-20160084779-A1 | NUCLEAR MAGNETIC RESONANCE IMPLEMENTED SYNTHETIC INDOLE AND INDAZOLE CANNABINOID DETECTION, IDENTIFICATION, AND QUANTIFICATION | HOFSTRA UNIVERSITY (US) | 2016-03-24 | — | — | US | disclosed |
| US-20160002195-A1 | CANNABINERGIC NITRATE ESTERS AND RELATED ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-07 | — | — | US | disclosed |
| US-20150152348-A1 | SYSTEMS AND METHODS FOR COLLECTING, TRANSPORTING AND REPURPOSING OR DESTROYING UNUSED PHARMACEUTICALS | SHARPS COMPLIANCE, INC. OF TEXAS | 2015-06-04 | — | — | US | disclosed |
| WO-2014176542-A1 | NUCLEAR MAGNETIC RESONANCE IMPLEMANTED SYNTHETIC INDOLE AND INDAZOLE CANNABINOID DENTECTION, IDENTIFICATION, AND QUANTIFICATION | HOFSTRA UNIVERSITY (US) | 2014-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002195-A1 | CANNABINERGIC NITRATE ESTERS AND RELATED ANALOGS | CNR2, CNR1, CHRNB3 | CNR2 1/4885CNR1 2/4885 |
| US-20170210728-A1 | Cannabinergic Nitrate Esters And Related Analogs | CNR2, CNR1, CHRNB3 | CNR2 1/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.